Free Trial

MEI Pharma (MEIP) SEC Filings & 10K Form

MEI Pharma logo
$4.85 -0.01 (-0.21%)
Closing price 09/2/2025 04:00 PM Eastern
Extended Trading
$4.88 +0.04 (+0.72%)
As of 06:39 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent MEI Pharma SEC Filings

DateFilerForm TypeView
08/26/2025
4:21 PM
MEI Pharma (Filer)
Form S-3/A
08/20/2025
4:56 PM
MEI Pharma (Issuer)
Riezman Joshua (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2025
4:54 PM
MEI Pharma (Issuer)
Riezman Joshua (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/12/2025
4:32 PM
MEI Pharma (Subject)
Schornstein Alexander (Filed by)
Form SCHEDULE 13G
08/05/2025
7:05 AM
MEI Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/30/2025
3:40 PM
MEI Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/29/2025
4:23 PM
CITADEL ADVISORS LLC (Filed by)
MEI Pharma (Subject)
Form SCHEDULE 13G
07/28/2025
6:20 PM
Anson Funds Management LP (Reporting)
MEI Pharma (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/23/2025
6:18 PM
Funicular Funds, LP (Reporting)
MEI Pharma (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/22/2025
4:22 PM
MEI Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/17/2025
8:33 PM
DRISCOLL FREDERICK W (Reporting)
MEI Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2025
8:36 PM
File Justin J. (Reporting)
MEI Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2025
8:36 PM
Flynn James P (Reporting)
MEI Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2025
8:38 PM
Glover Nicholas (Reporting)
MEI Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2025
8:39 PM
MEI Pharma (Issuer)
Reynolds Thomas C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2025
8:40 PM
MEI Pharma (Issuer)
Wood Steven D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
3:30 PM
MEI Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/20/2024
4:10 PM
MEI Pharma (Filer)
Form DEF 14A
12/20/2024
4:15 PM
MEI Pharma (Filer)
Form DEFA14A
12/20/2024
4:20 PM
MEI Pharma (Filer)
Form ARS
09/19/2024
4:20 PM
MEI Pharma (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
09/19/2024
4:05 PM
MEI Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:MEIP) was last updated on 9/3/2025 by MarketBeat.com Staff
From Our Partners